Results 211 to 220 of about 10,536,235 (262)
Some of the next articles are maybe not open access.
Antimalarials in Rheumatic Diseases
Australian and New Zealand Journal of Medicine, 1982The use of antimalarials in rheumatoid arthritis (RA) and systemic lupus erythematosis (SLE) has declined over recent years due to concern over retinal toxicity and the impression that this class of drugs is relatively ineffective in rheumatic diseases. Recent reviews suggest that this position should be changed. Firstly, there is now good evidence for
R O, Day +3 more
openaire +2 more sources
Rheumatic diseases and pregnancy
Current Opinion in Obstetrics & Gynecology, 2010This review discusses how inflammatory rheumatic diseases [rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE)] of the mother can influence the course of pregnancy and the development of the fetus. Antirheumatic drug therapy of the mother and strategies to prevent fetal complications namely in SLE must be considered with ...
Elisabeth, Märker-Hermann +1 more
openaire +2 more sources
Acute Rheumatism and Rheumatic Heart Disease
Journal of the Royal Sanitary Institute, 1951Although there has been a substantial decline in its prevalence during the last twenty years, acute rheumatism remains one of the most important diseases of the rheumatic group. Infection with hæmolytic streptococci of Group A is at present the only factor in the aetiology of acute rheumatism which can be identified with confidence.
openaire +2 more sources
Osteoarthritis and Rheumatic Disease
Postgraduate Medicine, 1967Although osteoarthritis affects a large proportion of the population, its causes and pathogenesis are not clearly understood. Gout, pseudogout, infectious arthritis, rheumatoid arthritis, pulmonary osteoarthropathy and polymyalgia rheumatica should be considered in differential diagnosis. Treatment is aimed largely at symptomatic relief.
openaire +2 more sources
Annals of the Rheumatic Diseases, 2020
It is currently unknown whether immunosuppressive and/or immunomodulating agents such as biological disease-modifying antirheumatic drugs (bDMARDs) affect the rate and the outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections
H. Schulze-Koops +4 more
semanticscholar +1 more source
It is currently unknown whether immunosuppressive and/or immunomodulating agents such as biological disease-modifying antirheumatic drugs (bDMARDs) affect the rate and the outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections
H. Schulze-Koops +4 more
semanticscholar +1 more source
Sulfasalazine in the rheumatic disease
Seminars in Arthritis and Rheumatism, 1988M OST PHYSICIANS are familiar with sulfasalazine (SSZ) as an agent commonly used to treat inflammatory bowel disease for more than 40 years. In 1978, McConkey et al reported preliminary studies suggesting that this sulfonamide might be effective in rheumatoid arthritis (RA).’ The use of SSZ arose from earlier open and controlled trials with a sulfone ...
openaire +2 more sources
Postgraduate Medicine, 1969
In rheumatic diseases such as acute rheumatic fever, rheumatoid arthritis, systemic lupus erythematosus, scleroderma, dermatomyositis and tuberculous arthritis, biopsy often helps to pinpoint a diagnosis. Many tissue changes, however, are nonspecific and the pathologist must interpret them in light of clinical information.
openaire +2 more sources
In rheumatic diseases such as acute rheumatic fever, rheumatoid arthritis, systemic lupus erythematosus, scleroderma, dermatomyositis and tuberculous arthritis, biopsy often helps to pinpoint a diagnosis. Many tissue changes, however, are nonspecific and the pathologist must interpret them in light of clinical information.
openaire +2 more sources
Apoptosis in rheumatic diseases
The American Journal of Medicine, 2000Apoptosis, or programmed cell death (PCD), is a form of cellular demise that occurs when cells are damaged or no longer needed. It plays an important role in embryogenesis, normal tissue homeostasis, as well as in certain pathologic conditions, such as in oncogenesis, acquired immunodeficiency syndrome (AIDS), certain neurodegenerative diseases, and in
T, Grodzicky, K B, Elkon
openaire +2 more sources
Annals of the New York Academy of Sciences, 2010
Opioids are the most potent analgesics available and are well established for the treatment of severe acute, surgical, and cancer pain. However, their use to ameliorate chronic noncancer pain (CNCP) is still controversial because of the side effects, such as tolerance, somnolence, confusion, constipation, addiction, withdrawal, and anxiety about ...
L J, Lang +3 more
openaire +2 more sources
Opioids are the most potent analgesics available and are well established for the treatment of severe acute, surgical, and cancer pain. However, their use to ameliorate chronic noncancer pain (CNCP) is still controversial because of the side effects, such as tolerance, somnolence, confusion, constipation, addiction, withdrawal, and anxiety about ...
L J, Lang +3 more
openaire +2 more sources
Introduction to Rheumatic Disease
Journal of the Royal Society of Health, 1990Rheumatic diseases are very common. They comprise one of the commonest causes of consultation by patients with general practitioners and hospital specialists. There are considerable financial implications for the community, as well as morbidity for the patient.
openaire +2 more sources